Marina Šagud

ORCID: 0000-0001-9620-2181
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Treatment of Major Depression
  • Stress Responses and Cortisol
  • Diet and metabolism studies
  • Electroconvulsive Therapy Studies
  • Neurotransmitter Receptor Influence on Behavior
  • Child and Adolescent Psychosocial and Emotional Development
  • Resilience and Mental Health
  • Posttraumatic Stress Disorder Research
  • Nerve injury and regeneration
  • Autism Spectrum Disorder Research
  • Pharmacological Effects and Toxicity Studies
  • Cardiac Health and Mental Health
  • Toxoplasma gondii Research Studies
  • Mental Health and Psychiatry
  • Pharmacogenetics and Drug Metabolism
  • Suicide and Self-Harm Studies
  • Electrolyte and hormonal disorders
  • Attention Deficit Hyperactivity Disorder
  • Hormonal Regulation and Hypertension
  • Psychology of Development and Education
  • Mental Health Research Topics
  • Receptor Mechanisms and Signaling

University Hospital Centre Zagreb
2016-2025

University of Zagreb
2016-2025

Klinika za psihijatriju Vrapče
2014-2024

Hologic (Germany)
2024

University of Mostar
2017

University of Osijek
2016

José de León Georgios Schoretsanitis Robert L. Smith Espen Molden Anssi Solismaa and 95 more Niko Seppälä Miloslav Kopeček Patrik Švancer I. Cánovas Olmos Carina Ricciardi Celso Iglesias García Ana Iglesias-Alonso Edoardo Spina Can‐Jun Ruan Chuanyue Wang Gang Wang Yi‐lang Tang Shih‐Ku Lin Hsien‐Yuan Lane Yong Sik Kim Se Hyun Kim Anto P. Rajkumar Dinora F. González‐Esquivel Helgi Jung–Cook Trino Baptista Christopher Rohde Jimmi Nielsen Hélène Verdoux Clélia Quilès Emílio J. Sanz Carlos De las Cuevas Dan Cohen Peter F.J. Schulte Aygün Ertuğrul A. Elif Anıl Yağcıoğlu Nitin Chopra Betsy McCollum Charles Shelton Robert O. Cotes Arun R. Kaithi John M. Kane Saeed Farooq Chee H. Ng John Bilbily Christoph Hiemke Carlos López‐Jaramillo Ian R. McGrane Fernando Lana Chin B. Eap Manuel Arrojo Flavian Ștefan Rădulescu Erich Seifritz Susanna Every‐Palmer Chad A. Bousman Emmanuel Bebawi Rahul Bhattacharya Deanna L. Kelly Yuji Otsuka Judit Lazáry Rafael Torres Agustín Yécora Mariano Motuca Sherry Kit Wa Chan Monica Zolezzi Sami Ouanes Domenico De Berardis Sandeep Grover Ric M. Procyshyn Richard A. Adebayo О.О. Кирилочев A. G. Soloviev Konstantinos Ν. Fountoulakis Alina Wilkowska Wiesław Jerzy Cubała Muhammad Ayub Alzira Silva Raphael M. Bonelli José María Villagrán Moreno Benedicto Crespo‐Facorro Henk Temmingh Eric Decloedt Maria Rosel Pedro Hiroyoshi Takeuchi Masaru Tsukahara Gerhard Gründer Marina Šagud Andreja Čelofiga Dragana Ignjatović Ristić Bruno Bertolucci Ortiz Hélio Elkis António Pacheco Palha Adrián LLerena Emilio Fernández-Egea Dan Siskind Abraham Weizman R. Masmoudi Shamin Mohd Saffian Jonathan G. Leung P.F. Buckley Stephen R. Marder

Abstract This international guideline proposes improving clozapine package inserts worldwide by using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest that is the third most toxic in United States (US), it produces four times higher pneumonia mortality than agranulocytosis or myocarditis. For trough steady-state serum concentrations, therapeutic reference range narrow, from 350 to 600 ng/mL with potential for toxicity ADRs as concentrations increase....

10.1055/a-1625-6388 article EN Pharmacopsychiatry 2021-12-15

Neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte (PLR), monocyte–lymphocyte (MLR) and systemic immune-inflammation index (SII index) are increasingly used as indicators of inflammation in different conditions, including schizophrenia. However, their relationship with negative symptoms, anhedonia, is largely unknown. Included were 200 patients schizophrenia 134 healthy controls (HC), assessed for physical anhedonia (PA), using the Revised Physical Anhedonia Scale (RPAS), social (SA) by...

10.3390/biom13020297 article EN cc-by Biomolecules 2023-02-04

A recent article in this journal presented a US perspective regarding the modernization of clozapine prescription and proposed an escape from long shadow cast by agranulocytosis.Here, international group collaborators discusses point view complementary to focusing on worldwide outcomes usage that may be uneven terms frequency adverse drug reactions.Studies Scandinavian national registries (Finland Denmark) did not find increased mortality patients or any clear evidence alleged toxicity...

10.1097/jcp.0000000000001678 article EN Journal of Clinical Psychopharmacology 2023-04-17

Abstract We examined and compared the relationship between religiosity symptom severity in patients with major depressive disorder (MDD) rated by Hamilton Depression Rating Scale) schizophrenia (rated Positive Negative Syndrome Scale). The Duke University Religion Index, Santa Clara Strength of Religious Faith (SCSORF) questionnaire, Brief Coping scale scores were similar MDD ( n = 50) 50). In MDD, higher organizational religious activity (ORA) (estimate 2.28, 95% confidence interval [CI]...

10.1097/nmd.0000000000001003 article EN The Journal of Nervous and Mental Disease 2019-05-03

Vuksan-Cusa B, Sagud M, Jakovljevic Mihaljevic Peles A, Jaksic N, S, Zivkovic Kudlek Mikulic Jevtovic S. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients bipolar disorder schizophrenia. Nord J Psychiatry 2012;Early Online:1–6. Background: Previous studies revealed high prevalence (MetS) C-Reactive (CRP) have also both emerged as independent risk factors for development cardiovascular disease (CVD) but are less...

10.3109/08039488.2012.745601 article EN Nordic Journal of Psychiatry 2012-12-11

Abstract Objective This cross‐sectional study investigated the association of physical and social anhedonia with suicidality in patients major depressive disorder (MDD), schizophrenia, non‐psychiatric controls. Method All participants completed revised Physical Anhedonia Scale (RPAS) Social (RSAS) were subdivided according to positive life‐time suicide attempt history. MDD evaluated Montgomery‐Ãsberg Depression Rating (MADRS), healthy respondents Patient Health Questionnaire‐9 (PHQ‐9),...

10.1111/sltb.12724 article EN Suicide and Life-Threatening Behavior 2020-12-14

Objective: Nightmares and insomnia in combat‐related post‐traumatic stress disorder (PTSD) might be resistant to treatment with selective serotonin reuptake inhibitors (SSRIs) benzodiazepines. Method: We describe five case reports of patients suffering from long‐lasting intractable nightmares insomnia. They were given different psychotropic agents past few years, no improvement their sleep disturbance. Olanzapine was added the current regimen. Results: Both improved rapidly after olanzapine...

10.1034/j.1600-0447.2003.00065.x article EN Acta Psychiatrica Scandinavica 2003-05-01

Extrapyramidal symptoms (EPSs) are common adverse effects of antipsychotics. The development acute EPSs could depend on the activity dopaminergic system and its gene variants. aim this study was to determine association between type 2 receptor (DRD2) dopamine transporter (SLC6A3) catechol-O-methyltransferase (COMT) polymorphisms in 240 male schizophrenic patients treated with haloperidol (15-mg/d) over a period weeks. Acute were assessed Simpson-Angus Scale. Three polymorphisms, DRD2 Taq1A,...

10.1097/jcp.0b013e31829abec9 article EN Journal of Clinical Psychopharmacology 2013-08-17
Coming Soon ...